Diffusion-weighted Imaging Is a Sensitive and Specific Magnetic Resonance Sequence in the Diagnosis of Ankylosing Spondylitis

REFERENCES

1. 1.↵
   1. van Gaalen FA,
   2. Bakker PA,
   3. de Hooge M,
   4. Schoones JW,
   5. van der Heijde D

   . Assessment of sacroiliitis by radiographs and MRI: where are we now? Curr Opin Rheumatol 2014;26:384–8.

   OpenUrl
2. 2.↵
   1. Weber U,
   2. Zhao Z,
   3. Rufibach K,
   4. Zubler V,
   5. Lambert RG,
   6. Chan SM,
   7. et al.

   Diagnostic utility of candidate definitions for demonstrating axial spondyloarthritis on magnetic resonance imaging of the spine. Arthritis Rheumatol 2015;67:924–33.

   OpenUrl
3. 3.↵
   1. Deodhar A

   . Sacroiliac joint magnetic resonance imaging in the diagnosis of axial spondyloarthritis: “a tiny bit of white on two consecutive slices” may be objective, but not specific. Arthritis Rheumatol 2016;68:775–8.

   OpenUrl
4. 4.↵
   1. Albers GW

   . Diffusion-weighted MRI for evaluation of acute stroke. Neurology 1998;51:S47–9.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Benz MR,
   2. Vargas HA,
   3. Sala E

   . Functional MR imaging techniques in oncology in the era of personalized medicine. Magn Reson Imaging Clin N Am 2016;24:1–10.

   OpenUrl
6. 6.↵
   1. Zhao YH,
   2. Li SL,
   3. Liu ZY,
   4. Chen X,
   5. Zhao XC,
   6. Hu SY,
   7. et al.

   Detection of active sacroiliitis with ankylosing spondylitis through intravoxel incoherent motion diffusion-weighted MR imaging. Eur Radiol 2015;25:2754–63.

   OpenUrl
7. 7.↵
   1. Pan C,
   2. Hu DY,
   3. Zhang W,
   4. Li XM

   . Role of diffusion-weighted imaging in early ankylosing spondylitis. Chin Med J (Engl) 2013;126:668–73.

   OpenUrl
8. 8.↵
   1. Sanal HT,
   2. Yilmaz S,
   3. Kalyoncu U,
   4. Cinar M,
   5. Simsek I,
   6. Erdem H,
   7. et al.

   Value of DWI in visual assessment of activity of sacroiliitis in longstanding ankylosing spondylitis patients. Skeletal Radiol 2013;42:289–93.

   OpenUrl
9. 9.↵
   1. Ai F,
   2. Ai T,
   3. Li X,
   4. Hu D,
   5. Zhang W,
   6. Morelli JN

   . Value of diffusion-weighted magnetic resonance imaging in early diagnosis of ankylosing spondylitis. Rheumatol Int 2012;32:4005–13.

   OpenUrlPubMed
10. 10.↵
    1. Bozgeyik Z,
    2. Ozgocmen S,
    3. Kocakoc E

    . Role of diffusion-weighted MRI in the detection of early active sacroiliitis. AJR Am J Roentgenol 2008;191:980–6.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Gaspersic N,
    2. Sersa I,
    3. Jevtic V,
    4. Tomsic M,
    5. Praprotnik S

    . Monitoring ankylosing spondylitis therapy by dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging. Skeletal Radiol 2008;37:123–31.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. van der Linden S,
    2. Valkenburg HA,
    3. Cats A

    . Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361–8.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Rudwaleit M,
    2. Landewe R,
    3. van der Heijde D,
    4. Listing J,
    5. Brandt J,
    6. Braun J,
    7. et al.

    The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 2009;68:770–6.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Maksymowych WP,
    2. Inman RD,
    3. Salonen D,
    4. Dhillon SS,
    5. Williams M,
    6. Stone M,
    7. et al.

    Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis Rheum 2005;53:703–9.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Dougados M,
    2. van der Heijde D,
    3. Sieper J,
    4. Braun J,
    5. Maksymowych WP,
    6. Citera G,
    7. et al.

    Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol 2014;66:2091–102.

    OpenUrl
16. 16.↵
    1. Maksymowych WP,
    2. Dougados M,
    3. van der Heijde D,
    4. Sieper J,
    5. Braun J,
    6. Citera G,
    7. et al.

    Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study. Ann Rheum Dis 2016;75:1328–35.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Song IH,
    2. Hermann K,
    3. Haibel H,
    4. Althoff CE,
    5. Listing J,
    6. Burmester G,
    7. et al.

    Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial. Ann Rheum Dis 2011;70:590–6.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Rudwaleit M,
    2. Schwarzlose S,
    3. Hilgert ES,
    4. Listing J,
    5. Braun J,
    6. Sieper J

    . MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis 2008;67:1276–81.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Xu M,
    2. Lin Z,
    3. Deng X,
    4. Li L,
    5. Wei Y,
    6. Liao Z,
    7. et al.

    The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor-alpha inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in China. Rheumatology 2011;50:1466–72.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Pedersen SJ,
    2. Sorensen IJ,
    3. Hermann KG,
    4. Madsen OR,
    5. Tvede N,
    6. Hansen MS,
    7. et al.

    Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors. Ann Rheum Dis 2010;69:1065–71.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Weiss A,
    2. Song IH,
    3. Haibel H,
    4. Listing J,
    5. Sieper J

    . Good correlation between changes in objective and subjective signs of inflammation in patients with short- but not long duration of axial spondyloarthritis treated with tumor necrosis factor-blockers. Arthritis Res Ther 2014;16:R35.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Lambert RG,
    2. Salonen D,
    3. Rahman P,
    4. Inman RD,
    5. Wong RL,
    6. Einstein SG,
    7. et al.

    Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2007;56:4005–14.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Maksymowych WP,
    2. Dhillon SS,
    3. Park R,
    4. Salonen D,
    5. Inman RD,
    6. Lambert RG

    . Validation of the spondyloarthritis research consortium of Canada magnetic resonance imaging spinal inflammation index: is it necessary to score the entire spine? Arthritis Rheum 2007;57:501–7.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Maksymowych WP,
    2. Salonen D,
    3. Inman RD,
    4. Rahman P,
    5. Lambert RG,
    6. Group CS

    . Low-dose infliximab (3 mg/kg) significantly reduces spinal inflammation on magnetic resonance imaging in patients with ankylosing spondylitis: a randomized placebo-controlled study. J Rheumatol 2010;37:1728–34.

    OpenUrlAbstract/FREE Full Text
25. 25.↵
    1. Dallaudiere B,
    2. Dautry R,
    3. Preux PM,
    4. Perozziello A,
    5. Lincot J,
    6. Schouman-Claeys E,
    7. et al.

    Comparison of apparent diffusion coefficient in spondylarthritis axial active inflammatory lesions and type 1 Modic changes. Eur J Radiol 2014;83:366–70.

    OpenUrl
26. 26.↵
    1. Boy FN,
    2. Kayhan A,
    3. Karakas HM,
    4. Unlu-Ozkan F,
    5. Silte D,
    6. Aktas I

    . The role of multi-parametric MR imaging in the detection of early inflammatory sacroiliitis according to ASAS criteria. Eur J Radiol 2014;83:989–96.

    OpenUrl
27. 27.↵
    1. Hededal P,
    2. Østergaard M,
    3. Sorensen IJ,
    4. Loft AG,
    5. Hindrup JS,
    6. Thamsborg G,
    7. et al.

    Development and validation of MRI sacroiliac joint scoring methods for the semiaxial scan plane corresponding to the Berlin and SPARCC MRI scoring methods, and of a new global MRI sacroiliac joint method. J Rheumatol 2018;45:70–7.

    OpenUrlAbstract/FREE Full Text
28. 28.↵
    1. Koh DM,
    2. Collins DJ,
    3. Orton MR

    . Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. AJR Am J Roentgenol 2011;196:1351–61.

    OpenUrlCrossRefPubMed